A Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

Summary

The purpose of this clinical study is to evaluate the safety and tolerability (side effects) and pharmacokinetics (drug levels in the body) of 80mg neflamapimod given twice daily in patients with dementia with Lewy bodies.

Timeline

Start

2024-10-16

Primary completion

2026-03-11

Completion

2026-03-25

Drugs

Indications